Missing/wrong data? Edit Wikidata item
High Response Rate and Durability Driven by HLA Genetic Diversity in Patients with Kidney Cancer Treated with Lenvatinib and Pembrolizumab
publication published on 26 May 2021
Author/s
author: Ed Reznik, Robert Motzer, Darren R Feldman, Yasuhiro Funahashi, Martin H Voss, Ritesh R Kotecha, Cristina Valero, Maria I Carlo, Samuel J Murray
Work details
Publication date:
May 26, 2021
Language:
Unknown
Country of origin:
Unknown
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.